CC
CATX icon

Commodore Capital’s Perspective Therapeutics CATX Stock Holding History

Commodore Capital’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.4M Buy
+6,336,782
New +$26.8M 1.53% 22
2024
Q4 		– Sell
-3,350,000
Closed -$44.7M – 34
2024
Q3 		$44.7M Sell
3,350,000
-1,307,345
-28% -$17.4M 2.79% 14
2024
Q2 		$46.4M Buy
4,657,345
+2,552,082
+121% +$36.9M 3.17% 14
2024
Q1 		$25.1M Buy
+2,105,263
New +$18M 1.68% 22

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Commodore Capital's CATX Position: Q1 2026 in Review

Commodore Capital opened a new position in Perspective Therapeutics (CATX) in Q1 2026: 6,336,782 shares worth $26.4M. The stake represents 1.53% of the portfolio and ranks #22 among its holdings. This is a return to the name: Commodore Capital previously reported a position in CATX as recently as Q3 2024.

Commodore Capital first reported a position in CATX in Q1 2024 and has held it in 4 quarters since. The position peaked at $46.4M in Q2 2024. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • Commodore Capital held 6,336,782 shares of Perspective Therapeutics worth $26.4M as of Q1 2026.
  • Perspective Therapeutics was a new Commodore Capital position in Q1 2026.
  • Perspective Therapeutics made up 1.53% of Commodore Capital's portfolio in Q1 2026, its #22 holding.
  • Commodore Capital first reported a position in Perspective Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • Commodore Capital's Perspective Therapeutics position peaked at $46.4M in Q2 2024.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Commodore Capital's 13F filing for Q1 2026, filed 15 May 2026.